Bilateral transient hearing loss associated with vincristine therapy: Case report
Küçük Resim Yok
Tarih
2000
Yazarlar
Dergi Başlığı
Dergi ISSN
Cilt Başlığı
Yayıncı
E I F T Srl
Erişim Hakkı
info:eu-repo/semantics/closedAccess
Özet
Vincristine, adriamycin, and dexamethasone (VAD) chemotherapy protocol is first-choice treatment in newly diagnosed multiple myeloma patients in many centers. Sudden hearing loss associated with vincristine therapy is a rarely observed event in the VAD protocol. We describe a 69-year old male patient diagnosed with multiple myeloma 7 months ago who developed sudden bilateral hearing loss related to vincristine therapy. This uncommon adverse effect of vincristine is discussed and the literature reviewed.
Açıklama
Anahtar Kelimeler
multiple myeloma, vincristine, hearing loss, toxicity
Kaynak
Journal of Chemotherapy
WoS Q Değeri
Q3
Scopus Q Değeri
Q3
Cilt
12
Sayı
6
